xBullRadar
XBR>
MACROLIVE

LoL: Kiwoom DRX Challengers vs BNK FearX Youth (BO3) - LCK Challengers League Rounds 3-4 Trial Group

Game 1 Winner100% 41.9pt 24h
// MARKET-IMPLIED PROBABILITIES
Game 1 Winner
100%
Match Winner
100%
O/U 2.5 Games
100%
Both Teams Slay a Dragon
100%
Both Teams Slay a Dragon
100%
Odd/Even Total Kills
100%
Both Teams Slay Baron Nashor
100%
Both Teams Slay a Dragon
100%
Both Teams Destroy Inhibitors
100%
Odd/Even Total Kills
100%
Any Player Quadra Kill
50%
Any Player Penta Kill
50%
Game 2 Winner
0%
Game Handicap: KRX.C (-1.5) vs BNK FearX Youth (+1.5)
0%
Both Teams Slay Baron Nashor
0%
Both Teams Destroy Inhibitors
0%
Any Player Quadra Kill
0%
Any Player Penta Kill
0%
Odd/Even Total Kills
0%
Both Teams Slay Baron Nashor
0%
Both Teams Destroy Inhibitors
0%
Any Player Quadra Kill
0%
Any Player Penta Kill
0%
VOLUME
$1.6M
24H VOLUME
$0
LIQUIDITY
$0
RESOLVES
Aug 11, 2026

Traders currently price "Game 1 Winner" at 100% for "LoL: Kiwoom DRX Challengers vs BNK FearX Youth (BO3) - LCK Challengers League Rounds 3-4 Trial Group". Over the past 24 hours that probability moved up 41.9 points. Full distribution: Game 1 Winner 100%, Match Winner 100%, O/U 2.5 Games 100%, Both Teams Slay a Dragon 100%. The market has traded $1.6M in total volume and resolves Aug 11, 2026. Kiwoom DRX Challengers enter this LCK Challengers League BO3 with a stronger 15-9 record in Rounds 3-4 compared to BNK FearX Youth's 9-14 mark, reflecting better recent form and consistency in the Trial Group. Prior head-to-head BO3s have split results, including a DRX 2-1 win in May. Roster continuity for DRX, anchored by returning players, supports their edge in map control and objective play, while FearX Youth seeks momentum shifts through aggressive early-game strategies. League positioning adds playoff implications, with both sides adapting to the current meta ahead of the August 11 matchup.

// MORE MACRO MARKETS

Odds sourced live from Polymarket, refreshed through the day. Prediction-market participation carries risk and may be restricted in your jurisdiction. Informational only — not investment advice.